Recent senatorial hearings reflect the move to convict UPFs (ultra-processed food) as the culprit responsible for society’s obesity and juvenile metabolic diseases “epidemics” while deflecting focus ...

The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association. Samuel D.

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Obesity surgery (also known as bariatric and metabolic surgery) is one of the most common reasons people engage in so-called ...

From Colombia to Uruguay to Argentina, Church donations and member volunteers bring increased health and hope to thousands.

When it opened in 1992 on the outskirts of São Paulo, Brazil, the Zu Lai temple was the first of its kind in the region.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Coming soon: Drugs for weight loss have been used for a long time in practice, however recent developments prompted the need for this special edition. The goals of this collection are to discuss ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Novo Nordisk, the Danish pharmaceutical giant, has announced slower growth projections for the upcoming year, following a remarkable doubling of sales for its obesity drug Wegovy in the final quarter ...